ISPOR and the Innovation and Value Initiative (IVI) are collaborating—with help from an expert advisory committee—to define a series of dialogues that highlight key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic. The webinar series will explore multiple viewpoints and focus on potential pathways for solutions in international and U.S.-focused health technology assessment and value assessment (VA/HTA).
Upcoming Webinar:
Fifth Installment
Using VA/HTA in Pursuing Innovation and Access in a Pandemic
DATE: November 12, 2020
TIME: 1:00PM EST | 5:00PM GMT | 7:00PM CET
Click here for time zone conversion
Description and Learning Objectives
Learning Objectives:
- Define US and global future research needs (methods, data, etc.) to support effective VA/HTA related to COVID-19
- Define important considerations to balance access, affordability, and incentives to innovate for diagnostics, treatments, and vaccines for COVID-19
- Discuss current public health gaps and how to prioritize necessary investment with limited resources
- Evaluate coordination of different stakeholders in the US, and cross-country collaboration
Speakers
• Richard Willke, PhD - Chief Science Officer, ISPOR, Lawrenceville, NJ, USA
Presented by:
• Adrian Towse, MA, MPhil - Director Emeritus, Office of Health Economics, London, UK
• Sung Hee Choe, MPH -Director, FasterCures, Washington D.C., USA
• Amitabh Chandra, PhD - Ethel Zimmerman Wiener Professor of Public Policy, HKS; Henry and Allison McCance Professor of Business Administration, HBS Harvard University Cambridge, MA, USA
• Rena Conti, PhD - Associate Professor, Markets, Public Policy, And Law
Associate Research Director, Institute For Health System Innovation And Policy, Questrom School of Business, Boston University, Boston, MA, USA
Watch Past Webinars On Demand
First Installment
July 29, 2020 - "How Should The COVID-19 Pandemic Challenge Conventional Wisdom About VA/HTA?"
Speakers
Moderator
Shelby Reed, PhD
Speakers
Finn Børlum Kristensen, MD, PhD
Darius Lakdawalla, PhD
Gary Puckrein, PhD
Michelle McMurry-Heath, MD, PhD
Speakers
Charles Phelps, PhD
Dan Ollendorf, PhD
Susan Griffin, PhD
Dr. Anirban Basu
Lou Garrison, PhD
Third Installment
September 21, 2020 - "Balancing Economics and Ethics: How Can VA/HTA Support Equitable Resource Allocation?"
Speakers
MODERATOR
Jennifer Bright, MPA
Executive Director
Innovation and Value Initiative (IVI)
Alexandria, VA, USA
SPEAKERS
Jennifer Miller, PhD
Assistant Professor
Yale University
New Haven, USA
Laurie Zephyrin, MD
Vice President, Delivery System Reform
The Commonwealth Fund
Washington DC, USA
Richard Cookson, DPhil
Professor, Center for Health Economics
University of York
York, UK
Amber Hewitt, PhD
Director, Health Equity
Families USA
Washington DC, USA
Fourth Installment
October 23, 2020 - The Role of Public Health – how can VA/HTA inform pandemic policy interventions and public resource allocation?
Speakers
Moderator:
Murray Ross, PhD
Vice President
Kaiser Foundation Health Plan, Inc.
Oakland, CA, USA
Speakers:
Yannis Natsis
Policy Manager Universal Access and Affordable Medicines
European Public Health Alliance (EPHA)
Brussels, Belgium
Reed Tuckson, MD, FACP
Managing Director
Tuckson Health Connections, LLC
Washington DC, USA
Marcus Keogh-Brown, PhD
Associate Professor
London School of Hygiene & Tropical Medicine
London, United Kingdom
Henning Tarp Jensen, PhD
Associate Professor of Macroeconomics and Simulation Modeling
London School of Hygiene & Tropical Medicine
London, United Kingdom
Penny Mohr, MA
Senior Advisor
Emerging Technology and Delivery System Innovation Research Initiatives
PCORI
Washington DC, USA